Mind Cure Archives - Green Market Report

StaffApril 21, 2023
shutterstock_152149322.jpg

2min00

After the market closed on Thursday, Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF)  announced its financial results for the quarter ending February 28, 2023.  All amounts are stated in Canadian dollars unless otherwise indicated.

The company had no revenue to report and C$200k in losses.

On March 16, 2022, Mind Cure announced that additional capital required to execute the company’s plan was unlikely to be found. Accordingly, the company made the decision to eliminate all expenditures outside those required to preserve the value of the company’s assets including its public company status with Canadian securities regulators and cash and cash equivalents.

The company noted in its filing that it has $6.1 million in cash and cash equivalents.

The company said it currently has no sources of cash from operations. Management estimates that it will be able to meet its obligations and sustain operations for at least the next twelve months.

As of Feb. 28, 2023, the company continued to hold equity in ATMA Journey Centers Inc., a privately held company, comprising of 1,250,000 common shares and 492,958 series A preference shares. As of February 28, 2023, the company determined its strategic equity investment in ATMA had a fair value of $nil.


Debra BorchardtJanuary 26, 2023
shutterstock_1021410481-scaled.jpg

3min00

After the market closed on Wednesday, Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) announced its financial results for the quarter ending November 30, 2022. Keep in mind that last year in March, Mind Cure announced it needed more money and that was unlikely to be found. Accordingly, Mind Cure made the decision to eliminate all expenses outside those required to preserve the value of its assets including its public company status with Canadian securities regulators and cash and cash equivalents.

At the end of November, the company had $6.4 million in cash and cash equivalents. The company had a comprehensive loss at the end of the quarter of $432,130. The company currently has no sources of cash from operations. Management said in the filing that it estimates it will be able to meet its obligations and to sustain operations for at least the next twelve months.

In addition to that, Robert Hill has resigned as a director of the company’s board of directors effective January 1, 2023.  Stephen Inouye has replaced Mr. Hill on the company’s board of directors.  “On behalf of the board of directors and the Company, I would like to thank Rob for his contribution and support.” stated Philip Tapley, CEO and Chair of the board of directors of MINDCURE.  “I would also like to welcome Steve to the board of directors.  Steve has been working with the Company in various roles since the Company’s inception.”

As of November 30, 2022, Mind Cure said it had $33,455 in accounts payable and accrued liabilities due to related parties (2021 – $76,890).

Becoming LNG Energy

On November 18, 2022, the company signed a binding Letter of Intent with LNG Energy Group Inc., a private company focused on the acquisition of natural gas production and exploration assets in Latin America, after which the company will become the holder of all of the issued and outstanding securities in the capital of LNG Energy. It is intended that the Transaction will constitute a reverse takeover of the company by the shareholders of LNG Energy. In connection with the proposed transaction, the company will complete a 2.4-1 consolidation of its shares and change its name to LNG Energy Group Inc. In connection with the Transaction, LNG Energy will complete a private placement of subscription receipts for proceeds of between $15m and $35m at a subscription price of at least C$0.20 per subscription. Further, LNG Energy will complete a non-convertible debt financing of between $65m and $85m. The Company will further complete a non-brokered private placement for total proceeds of approximately $1m at a price of $0.05 per unit.


StaffMarch 16, 2022
daily-hit.jpg

6min00

The Daily Hit is a recap of the day’s top business news in the cannabis industry for March 16, 2022.

 

On The Site

TerrAscend

TerrAscend Corp. (CSE: TER) ( OTCQX: TRSSF) reported its financial results for the fourth quarter and full year periods ending December 31, 2021. Net sales in the fourth quarter were $49.2 million as compared to $49.1 million in the third quarter and $49.6 million for the same time period last year. The net loss was $5.9 million versus last year’s net loss of $94 million. TerrAscend said the loss was mainly related to a one-time loss of $3.3 million in lease termination fees, $6.9 million of finance and other expenses, $6.9 million of accrued income taxes, and $2.0 million of transaction costs mostly related to the Gage acquisition. These expenses were partially offset by a $14.4 million non-cash gain on fair value of warrant liability. Read more here.

Russians

Law360 reported that federal prosecutors on Monday unsealed the indictment against a Russian tycoon accused of making illegal political contributions in support of a cannabis venture, claiming that he made the donations in the names of straw donors. According to the Justice Department, the group hoped that the donations  to certain candidates would help Muraviev and his business partners win the coveted cannabis and marijuana licenses. Read more here.

Mind Cure

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) announced that it is shutting down after determining it can’t raise the money it needs to continue. The stock stopped trading when the news was announced but did resume after a few hours and fell by 38%. Mind Cure said it will cut all of its C-suite executives and employees, other than its Chief Financial Officer, Vice President of Engineering and certain administrative staff required to wind-down the company’s operations and for limited care and maintenance of the company; and halt all non-committed expenditures related to the development and marketing work of its iSTRYM product, the research and development related to its synthetic ibogaine program, and the research and development related to its Desire Project. Mr. Philip Tapley, the Chair of the Company’s board of directors, will assume the role of the Company’s interim CEO. Read more here. 

In Other News

Trulieve

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) launched its nationwide Supplier Diversity Initiative. The initiative provides education and professional development resources, while creating mutually beneficial business relationships with a supplier base reflective of the customers and communities Trulieve serves. Read more here.

Raw Garden

Raw Garden, the Santa Barbara based premier cannabis brand is expanding into an entirely new product category with the launch of infused cannabis joints. These 100% pure cannabis joints are infused with micronized refined live resin crushed diamonds, and will be available for purchase at dispensaries across California soon.


Debra BorchardtMarch 16, 2022
shutterstock_1158656905.jpg

4min00

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) announced that it is shutting down after determining it can’t raise the money it needs to continue. The stock stopped trading when the news was announced but did resume after a few hours and fell by 38%.

Mind Cure said it will cut all of its C-suite executives and employees, other than its Chief Financial Officer, Vice President of Engineering and certain administrative staff required to wind-down the company’s operations and for limited care and maintenance of the company; and halt all non-committed expenditures related to the development and marketing work of its iSTRYM product, the research and development related to its synthetic ibogaine program, and the research and development related to its Desire Project. Mr. Philip Tapley, the Chair of the Company’s board of directors, will assume the role of the Company’s interim CEO.

“Though we continue the Strategic Review Process, we have identified no available strategic alternatives that would require further development and execution of MINDCURE’s existing business plan. As a result, we have determined that the Company should immediately move to reduce all non-necessary expenditures except as required to preserve the value of the Company’s cash balance and other assets,” said the Chair of MINDCURE’s Special Committee, Jason Pamer.

Mind Cure said that the company’s Special Committee “determined that the additional capital required to execute the company’s business plan is unlikely to be found under the current and foreseeable market conditions and that none of the strategic alternatives available to the company necessitated ongoing developmental expenditures. Accordingly, the Board has taken the decision to immediately eliminate all expenditures outside those required to preserve the value of the company’s assets, including its public company status with Canadian securities regulators and cash and cash equivalents of approximately $10.57 million on an unaudited basis as at close of business yesterday and without adjusting for any current liabilities as at such date or arising from the elimination of expenditures described in this news release.”

“While we truly appreciate the impact of these changes on our team and our suppliers, our Strategic Review Process has led us to believe that the actions announced in this news release are necessary to preserve cash position and maintain value of the Company’s other assets while the Company continues to seek a strategic transaction,” said the Chair of MINDCURE’s Board of Directors and Interim CEO, Philip Tapley. “Also, on behalf of the Board, I would like to thank Kelsey Ramsden for her dedicated service to the Company which began shortly after the Company went public in 2020. We are grateful to Kelsey for her strong leadership on behalf of all stakeholders.”

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.